Home / Share Price Target / Par
Par Drugs and Share Price Target 2024, 2025, 2026 to 2039 With Charts
Par Drugs and Chemicals Limited | |||
 | Symbol: PAR | ||
| Price: ₹271.1 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Par Drugs and Brief Company Overview
- 1.1: Par Drugs and Chemicals Limited: A Reputable Pharma Player
- 1.2: Par Drugs and Financial Performance
- 1.2.1: Is Par Drugs and A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Par Drugs and Share Price Target For 2024
- 2.1.1: Par Drugs and Share Price Target Table For 2024
- 2.1.2: Summary: Par Drugs and Share Price Prediction For 2024
- 2.2: Par Drugs and Share Price Target For 2025
- 2.2.1: Par Drugs and Share Price Target Table For 2025
- 2.2.2: Summary: Par Drugs and Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Par Drugs and Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Par Drugs and Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Par Drugs and Past Performance
Par Drugs and Brief Company Overview
Par Drugs and Chemicals Limited: A Reputable Pharma Player
Established in 1982, Par Drugs and Chemicals Limited is a well-respected Indian company in the pharmaceutical industry. Headquartered in Vadodara, the company specializes in developing, manufacturing, and distributing a wide range of active pharmaceutical ingredients.
Par Drugs and Chemicals Limited has a strong reputation for its commitment to quality and innovation.
Diverse Product Offerings:
- Magnesium salts
- Dried aluminum hydroxide gel
- Sodium aluminum silicate
- Precipitated silica
- Magnesium silicate
- Colloidal silicon dioxide
- Sucralfate USP
- Amorphous and blended products
The company's diverse product portfolio caters to various therapeutic areas and meets the needs of pharmaceutical manufacturers globally.
Advertisement
Par Drugs and Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 332.07 Crore | Market valuation of Par Drugs and's shares. |
| Revenue (TTM) | 97.31 Crore | Total revenue generated by Par Drugs and over the past twelve months. |
| Net Income (TTM) | +14.22 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 18.18% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 14.62% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +4.7% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | +83.2% | Change in earnings compared to the same quarter last year. |
| Total Cash | 29.85 Crore | Total amount of liquid funds available to Par Drugs and. |
| Beta | 0.25 | Beta is less than 1 indicating that the Par Drugs and's price is less volatile than the market. |
Is Par Drugs and A Good Buy For Long Term?
Par Drugs, a small-cap stock, exhibits impressive financial performance with a significant change in earnings (83.2%) and a healthy profit margin (14.62%). Its recent quarterly returns are promising, and long-term returns have been substantial (540.41% in 3 years). With a strong cash balance and consistent revenue growth, Par Drugs presents itself as a potentially lucrative investment for long-term growth.
To predict the Par Drugs and's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Par Drugs and Share Price Target For 2024
The line chart displays the monthly closing prices of Par Drugs and with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Par Drugs and shares in 2024, see the table below.
Advertisement
Par Drugs and Share Price Target Table For 2024
| Par Drugs and's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 279.86 (+3.23%) | Fibonacci Extension Level 123.6% |
| 2024 Target 2 | 276.23 (+1.89%) | Custom Fibonacci Extension Lvl 64.9% |
| 2024 Target 1 | 272.96 (+0.68%) | Custom Fibonacci Extension Lvl 23.6% |
| Current Price | 271.10 | Par Drugs and's 1 share price as of Thu 14 Nov 2024 |
| Stop Loss 1 | 270.21 (-0.33%) | Fibonacci Retracement Level 98.6% |
| Stop Loss 2 | 266.94 (-1.54%) | Fibonacci Retracement Extended 40% |
| Stop Loss 3 | 263.57 (-2.78%) | Fibonacci Retracement Extended 82.6% |
Summary: Par Drugs and Share Price Prediction For 2024
In summary, Par Drugs and has surged by ₹55.40, achieving a notable +25.68% increase from 1st January 2024 to 14 Nov 2024. Our analysis of Par Drugs and for 2024 predicts an additional rise of 0.68% to 3.23% by the end of 2024 with three potential targets T1: 272.96, T2: 276.23, T3: 279.86. Stop Loss at SL1: 270.21, SL2: 266.94, SL3: 263.57.
Par Drugs and has a 52-week high of ₹325.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹190.14, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Par Drugs and.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Par Drugs and Share Price Target For 2025
The line chart displays the monthly closing prices of Par Drugs and with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Par Drugs and shares in 2025, see the table below.
Advertisement
Par Drugs and Share Price Target Table For 2025
| Par Drugs and's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 352.30 (+29.95%) | Fibonacci Extension Level 150% |
| 2025 Target 2 | 344.67 (+27.13%) | Price Action: Chart |
| 2025 Target 1 | 341.26 (+25.87%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 271.10 | Par Drugs and's 1 share price as of Thu 14 Nov 2024 |
| Stop Loss 1 | 255.00 (-5.94%) | Price Action: 21 Oct 2024 High |
| Stop Loss 2 | 252.45 (-6.88%) | Price Action: Chart |
| Stop Loss 3 | 248.00 (-8.53%) | Price Action: Nov 2023 High |
Summary: Par Drugs and Share Price Prediction For 2025
In summary, Par Drugs and has surged by ₹55.40, achieving a notable +25.68% increase from 1st January 2024 to 14 Nov 2024. Our analysis of Par Drugs and for 2025 predicts an additional rise of 25.87% to 29.95% by the end of 2025 with three potential targets T1: 341.26, T2: 344.67, T3: 352.30. Stop Loss at SL1: 255.00, SL2: 252.45, SL3: 248.00.
Par Drugs and has a All-Time high of ₹325.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹190.14, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Par Drugs and, we have created a specific page for that check here: Par Drugs and Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Par Drugs and Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Par Drugs and share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 13.33% over the next 15 years.
For complete year by year Par Drugs and long term share price target from 2024, 2025 to 2039 check the below table.
Par Drugs and Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Par Drugs and Target | YoY Change % |
|---|---|---|
| 2024 | ₹271.1 | [Current Price] |
| 2024 | ₹300.44 | 10.82% |
| 2025 | ₹383.32 | 27.58% |
| 2026 | ₹495.86 | 29.35% |
| 2027 | ₹628.49 | 26.74% |
| 2028 | ₹680.4 | 8.25% |
| 2029 | ₹784.61 | 15.31% |
| 2030 | ₹850.5 | 8.39% |
| 2031 | ₹981.76 | 15.43% |
| 2032 | ₹1,143.43 | 16.46% |
| 2033 | ₹1,159.39 | 1.39% |
| 2034 | ₹1,268.78 | 9.43% |
| 2035 | ₹1,317.67 | 3.85% |
| 2036 | ₹1,467.65 | 11.38% |
| 2037 | ₹1,658.36 | 12.99% |
| 2038 | ₹1,638.37 | -1.21% |
| 2039 | ₹1,732.19 | 5.72% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Par Drugs and Past Performance
- In 2019, Par Drugs and opening price was ₹24.02
- As of Thu 14 Nov 2024 the price stands at ₹271.1.
- This represents a Compound Annual Growth Rate (CAGR) of 49.77%.
- In 5 years, an investment of 10,000 would have become ₹1.12 Lakh.
As we wrap up, we hope you like our study on Par Drugs and share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- Par Drugs and Share Price History
- Par Drugs and Price Target Tomorrow
- Par Drugs and Dividend History
- Par Drugs and Bonus History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
